2025-05-29 - Analysis Report
Okay, here's a comprehensive analysis of Eli Lilly and Co (LLY) based on the provided data. The report is in English with numerical summaries and analysis.

## Eli Lilly and Co (LLY) Stock Analysis

**Ticker:** LLY
**Company Name:** Eli Lilly and Co
**Description:** A global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

### 1. Performance vs. S&P 500 (VOO)

*   **LLY Cumulative Return:** 241.84%
*   **VOO Cumulative Return:** 82.09%
*   **Absolute Divergence:** 159.7
*   **Divergence Range:** Max: 313.1, Min: -27.6
*   **Relative Divergence:** 55.0 (Indicates the current divergence is in the 55th percentile of its historical range)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO) over the period. The relative divergence of 55.0 suggests that while LLY is performing much better, there is still room to grow.

### Alpha, Beta Analysis

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | ------ | ----- | ------- | ------ | ------ |
| 2015-2017  | 10.0%  | 56.3% | -19.0%  | 0.1    | 67.5   |
| 2016-2018  | 38.0%  | 58.6% | 20.0%   | -0.1   | 94.9   |
| 2017-2019  | 49.0%  | 58.6% | 19.0%   | 0.3    | 110.2  |
| 2018-2020  | 51.0%  | 58.6% | 25.0%   | 0.1    | 144.4  |
| 2019-2021  | 105.0% | 60.6% | 50.0%   | 0.3    | 239.8  |
| 2020-2022  | 100.0% | 65.0% | 94.0%   | 0.3    | 321.9  |
| 2021-2023  | 139.0% | 65.0% | 122.0%  | 0.3    | 518.0  |
| 2022-2024  | 156.0% | 72.2% | 139.0%  | 0.3    | 690.4  |
| 2023-2025  | 92.0%  | 76.8% | 62.0%   | 0.2    | 645.8  |

**Analysis:**

*   **CAGR:** High, especially in recent years, reflecting strong growth.
*   **MDD:** Relatively high, indicating significant drawdowns, suggesting the stock can be volatile.
*   **Alpha:** Consistently positive and high in recent years, showing LLY is generating returns above what would be expected based on market movements.
*   **Beta:** Low, suggesting LLY is less sensitive to market movements.
*   **Cap:** Increasing steadily, showing the market capitalization is expanding.

### 2. Recent Stock Price Movement

*   **Current Price:** 719.39
*   **Last Market Data:** {'price': 719.39, 'previousClose': 725.22, 'change': -0.8}
*   **5-Day Moving Average:** 719.69
*   **20-Day Moving Average:** 758.27
*   **60-Day Moving Average:** 797.78

**Analysis:** The stock price is currently below its 5-day, 20-day, and 60-day moving averages, indicating a short-term downtrend. The recent price decrease {'price': 719.39, 'previousClose': 725.22, 'change': -0.8} indicates a short-term downward fluctuation.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 36.55 (Approaching oversold territory)
*   **PPO:** -0.42 (Below zero, indicating a potential downtrend)
*   **Hybrid Signal:** cash_69%_Sell 69.8% of holdings (397 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Divergence Change:** -0.7 (Negative, indicating recent underperformance relative to VOO)
*   **Expected Return:** 126.7% (Long-term excess return vs. S&P 500 if investing now)

**Analysis:**
* MRI indicates Low Risk
*   The RSI suggests that the stock might be approaching oversold conditions, which could signal a potential buying opportunity. The PPO, being negative, confirms the short-term downtrend.
*   The Hybrid Signal suggests reducing holdings significantly, indicating caution.
*   The negative change in relative divergence further supports the recent underperformance.
*   Despite the short-term caution signals, the high expected return indicates strong long-term potential.

### 4. Recent News & Significant Events

*   **[2025-05-25]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-29]:** Analysts discussing recent performance and outlook.
*   **[2025-05-27]:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-28]:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news indicates significant activity around LLY, including potential catalysts and volatility drivers. Investors should monitor company announcements and news closely.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
| ---------- | ---- | ----------- |
| 2025-05-01 | 3.07 | 12.73 B$    |
| 2024-10-30 | 1.08 | 11.44 B$    |
| 2024-08-08 | 3.29 | 11.30 B$    |
| 2024-04-30 | 2.49 | 8.77 B$     |
| 2025-05-01 | 2.49 | 8.77 B$     |

**Analysis:** The earnings data shows a strong upward trend in both EPS and revenue, indicating solid financial performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
| ---------- | -------- | ------------- |
| 2025-03-31 | $12.73B | 82.53%        |
| 2024-12-31 | $13.53B | 82.24%        |
| 2024-09-30 | $11.44B | 81.02%        |
| 2024-06-30 | $11.30B | 80.80%        |
| 2024-03-31 | $8.77B  | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE      |
| ---------- | -------- | -------- |
| 2025-03-31 | $15.76B | 17.50%   |
| 2024-12-31 | $14.19B | 31.07%   |
| 2024-09-30 | $14.24B | 6.81%    |
| 2024-06-30 | $13.56B | 21.88%   |
| 2024-03-31 | $12.81B | 17.51%   |

**Analysis:** The financial information demonstrates strong and consistent revenue growth, high profit margins, increasing equity, and fluctuating but generally healthy ROE.

### 7. Overall Analysis

**Summary:**

Eli Lilly and Co (LLY) has shown exceptional historical performance compared to the S&P 500. Recent performance shows a slight dip below its moving averages, the MRI indicates Low Risk, and the hybrid signal suggests selling some stocks. The RSI is approaching oversold territory, and the PPO is negative, but the long-term expected return remains very high. Financial data shows a solid increase in revenue and profit margins, but the recent news suggests volatility.

**Recommendation:**

Given the high long-term expected return and the current RSI and PPO values, and hybrid signal, it appears to be a good idea to sell stocks to preserve cash for future investment opportunities. Investors should closely monitor the news and earning reports.
